EU Working To Increase Rx-to-OTC Switches Through Centralized Procedure
This article was originally published in The Tan Sheet
Executive Summary
Despite the availability of a centralized procedure for Rx-to-OTC switches in the European Union, member states and stakeholders in the drug industry are still working toward streamlining regulatory and approval processes, and working toward the development of a single market